BIOMARKER:

CDCA3 overexpression

Entrez ID:

CDCA3 overexpression CDCA3 overexpression	Non Small Cell Lung Cancer NSCLC	carboplatin Sensitive: C3 – Early Trials Commun Biol - 3 weeks
CDCA3 overexpression CDCA3 overexpression	Non Small Cell Lung Cancer NSCLC	cisplatin Sensitive: C3 – Early Trials Commun Biol - 3 weeks

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

Associations